1. Choudhury A, Lip GY. Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice. Pathophysiol Haemost Thromb. 2003. 33:282–289.
2. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D'Agostino RB. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med. 1998. 158:229–234.
3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke. Stroke. 1991. 22:983–988.
4. Korea National Statistical Office. Annual report on the cause of death statistics. 2007. Seoul: Korea National Statistical Office.
5. Jee SH, Park JW, Lee SY, et al. Stroke risk prediction model: a risk profile from the Korean study. Atherosclerosis. 2008. 197:318–325.
6. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. JAMA. 1994. 271:840–844.
7. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997. 96:2455–2461.
8. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention. JAMA. 2001. 285:2370–2375.
9. Ayer JG, Almafragy HS, Patel AA, Hellyer RL, Celermajer DS. Body mass index is an independent determinant of left atrial size. Heart Lung Circ. 2008. 17:19–24.
10. Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity: results of a meta-analysis. Am Heart J. 2008. 155:310–315.
11. Dublin S, French B, Glazer NL, et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med. 2006. 166:2322–2328.
12. Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004. 292:2471–2477.
13. Kim BG, Park JT, Ahn Y, Kimm K, Shin C. Geographical difference in the prevalence of isolated systolic hypertension in middle-aged men and women in Korea. J Hum Hypertens. 2005. 19:877–883.
14. Shin C, Abbott RD, Lee H, Kim J, Kimm K. Prevalence and correlates of orthostatic hypotension in middle-aged men and women in Korea. J Hum Hypertens. 2004. 18:717–723.
15. World Health Organization. International Association for the Study of Obesity. International Obesity Taskforce. The Asia-Pacific Perspective: Redefining obesity and its treatment. 2000. Sydney: Health Communications.
16. Jeong JH. Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years. J Korean Med Sci. 2005. 20:26–30.
17. Kim YH, Kwak CH, Kim NH, et al. Korean Atrial Fibrillation Registry (KORAF). Korean Circ J. 2007. 37:Suppl 3. 23.
18. Kim HJ, On YK, Sung J, et al. Risk factors for predicting new-onset atrial fibrillation in persons who received health screening tests. Korean Circ J. 2007. 37:609–615.
19. Ohsawa M, Okayama A, Sakata K, et al. Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000. J Epidemiol. 2005. 15:194–196.
20. Yap KB, Ng TP, Ong HY. Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: a population-based study. J Electrocardiol. 2008. 41:94–98.
21. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation. Circulation. 2004. 110:1042–1046.
22. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006. 295:1549–1555.
23. Korea Centers for Disease Control and Prevention. Report on national health and nutrition survey 2005. 2007. Seoul: KCDC.
24. Watanabe H, Tanabe N, Watanabe T, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation. 2008. 117:1255–1260.